Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 15/20 | 0.47 |
| ▸ | NPY1R | P25929 | 9/20 | 0.47 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.38 |
| ▸ | NPY2R | P49146 | 5/20 | 0.38 |
| ▸ | MME | P08473 | 1/20 | 0.37 |
| ▸ | NMT2 | O60551 | 1/20 | 0.35 |
| ▸ | NMT1 | P30419 | 1/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18671824 | 0.95 | NPY4R (0.47) | NPY4RNPY1RNPY5RNPY2RMME | |
| SCHEMBL16263594 | 0.93 | NPY4R (0.49) | NPY4RNPY1RNPY5RNPY2RFOLH1 | |
| SCHEMBL18671027 | 0.88 | NPY4R (0.44) | NPY4RNPY1RNPY5RNPY2RNMT2 | |
| SCHEMBL16263595 | 0.88 | NPY4R (0.48) | NPY4RNPY1RNPY5RNPY2RNMT2 | |
| SCHEMBL18671023 | 0.87 | TGFBR1 (0.41) | NPY4RNPY1RNPY5RNPY2RMME | |
| SCHEMBL23048407 | 0.86 | NPY4R (0.43) | NPY4RNPY1RNPY5RNPY2RFOLH1 | |
| SCHEMBL8005035 | 0.86 | NPY4R (0.43) | NPY4RNPY1RNPY5RNPY2RFOLH1 | |
| SCHEMBL13949746 | 0.86 | NPY4R (0.43) | NPY4RNPY1RNPY5RNPY2RFOLH1 | |
| SCHEMBL18671029 | 0.86 | NPY4R (0.41) | NPY4RNPY1RNPY5RNPY2RNMT2 | |
| SCHEMBL18671822 | 0.85 | NPY4R (0.44) | NPY4RNPY1RNPY5RNPY2RNMT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9605013-B2 | Derivatives of hemin with antibacterial and antiviral activity | Obschestvo S Ogranichennoi Otvetstvennostiyu “Pharmenterprises” (RU) | 2017-03-28 | — | — | US | disclosed |